Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARAPS Study: Comparison of Portal Vein Embolization With Radiofrequency Ablation Versus Portal Vein Embolization Alone for Accelerated Liver Regeneration: A Randomized Controlled Trial

NCT04107324 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04107324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04107324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARAPS Study: Comparison of Portal Vein Embolization With Radiofrequency Ablation Versus Portal Vein Embolization Alone for Accelerated Liver Regeneration: A Randomized Controlled Trial
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2020
Completion date
May 1, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver failure, liver metastases, liver regeneration